Clinical trials
Completed Nasopharyngeal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 10 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 7 |
| Sun Yat-sen University | 7 |
| Chinese University of Hong Kong | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Dana-Farber Cancer Institute | 3 |
| M.D. Anderson Cancer Center | 3 |
| Sanofi | 3 |
| University Health Network, Toronto | 3 |
| Baylor College of Medicine | 2 |
| Cancer Research UK | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Neoplasms | 96 |
| Head and Neck Neoplasms | 36 |
| Oropharyngeal Neoplasms | 30 |
| Hypopharyngeal Neoplasms | 28 |
| Laryngeal Neoplasms | 28 |
| Mouth Neoplasms | 27 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Lung Neoplasms | 15 |
| Nasopharyngeal Carcinoma | 13 |
| Small Cell Lung Carcinoma | 13 |
Trials
Showing 26 to 50 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.